替代癌症治療市場－全球產業規模、佔有率、趨勢、機會和預測，按治療類型、疾病類型、最終用戶、地區和競爭細分，2020 年至 2030 年

2024年，全球替代癌症治療市場規模達156.5億美元，預計2030年將達269.4億美元，預測期內複合年成長率為9.62%。隨著越來越多的患者尋求非傳統療法來輔助或替代化療和放療等傳統療法，全球替代癌症治療市場正在迅速擴張。該市場涵蓋多種療法，包括草藥、免疫療法以及旨在增強人體自然防禦能力的生物製劑（例如細胞激素療法和單株抗體）。推動該市場成長的一個重要因素是患者和醫療保健提供者對傳統癌症治療潛在副作用的認知不斷提高。因此，對有望改善患者生活品質、減少副作用和增強治療效果的補充療法和替代療法的需求日益成長。免疫療法尤其受到廣泛關注，因為它能夠更有選擇性地靶向和攻擊癌細胞，從而減少對健康組織的損害。 2024 年 6 月，美國食品藥物管理局 (FDA) 批准 epcoritamab-bysp（Epkinly，Genmab US, Inc.）用於治療已接受兩線或兩線以上全身治療的複發或難治性濾泡性淋巴瘤 (FL) 成年患者。

關鍵市場促進因素

癌症發生率上升

主要市場挑戰

缺乏標準化監管

主要市場趨勢

傳統療法與替代療法的整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球替代癌症治療市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依治療類型（荷爾蒙療法、針灸和膳食補充劑等）
  • 依疾病類型（胃腸道癌、肺癌、乳癌、大腸癌、白血病、淋巴瘤、黑色素瘤、攝護腺癌、其他）
  • 按最終使用者（醫院和診所、癌症和放射治療中心、家庭護理、其他）
  • 按地區
  • 按公司分類（2024）
• 產品市場圖
  • 按治療類型
  • 依疾病類型
  • 按最終用戶
  • 按地區

第6章：北美替代癌症治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲替代癌症治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區替代癌症治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲替代癌症治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲替代癌症治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 癌症發生率不斷上升
• 醫療支出不斷成長
• 挑戰
• 缺乏對新療法的認知
• 治療費用高昂

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球替代癌症治療市場：SWOT 分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• Innovative Medicine, LLC
• Northwest Natural Health Clinic
• Immunotherapy Institute
• Georgia Cancer Specialists
• Holistic Bio Spa
• Johnson & Johnson
• Celgene Corporation
• Astellas Pharma, Inc.
• Novartis AG
• Merck KGaA

第 16 章：策略建議

第17章調查會社について,免責事項

Global Alternative Cancer Therapeutics Market was valued at USD 15.65 billion in 2024 and is expected to reach USD 26.94 billion by 2030 with a CAGR of 9.62% during the forecast period. The global alternative cancer therapeutics market is rapidly expanding as more patients seek non-traditional treatments alongside or in place of conventional therapies like chemotherapy and radiation. This market encompasses a wide range of therapies, including herbal medicines, immune-based treatments, and biologics, such as cytokine therapies and monoclonal antibodies, which aim to enhance the body's natural defenses. One significant driver behind the growth of this market is the increasing awareness among patients and healthcare providers about the potential side effects of conventional cancer treatments. As a result, there is a rising demand for complementary and alternative therapies that promise to improve patient quality of life, reduce side effects, and enhance treatment outcomes. Immunotherapies, in particular, have gained significant traction due to their ability to target and attack cancer cells more selectively, causing less harm to healthy tissues. In June 2024, the U.S. Food and Drug Administration (FDA) approved epcoritamab-bysp (Epkinly, Genmab U.S., Inc.) for adult patients with relapsed or refractory follicular lymphoma (FL) following two or more lines of systemic therapy.

Key Market Drivers

Rising Cancer Incidence

The rising global incidence of cancer is a significant driver of the alternative cancer therapeutics market. For instance, according to the WHO 2025 report, cancer is a leading global cause of death, responsible for nearly 10 million deaths in 2020, or one in six deaths. Common cancers include breast, lung, colon, rectum, and prostate. One-third of cancer deaths are linked to tobacco, obesity, alcohol, poor diet, physical inactivity, and air pollution. As the number of cancer diagnoses continues to increase worldwide, there is a growing demand for diverse treatment options, including alternative therapies. The global cancer burden is influenced by various factors, such as aging populations, lifestyle changes, and environmental exposures. With the traditional cancer treatment methods like chemotherapy and radiation often resulting in harsh side effects, patients are increasingly seeking complementary or alternative approaches to manage their condition and improve their overall well-being. According to the WHO, cancer affects 1 in 5 people, with 1 in 12 women and 1 in 9 men impacted. In 2022, there were 20 million new cancer cases and 9.7 million deaths, while 53.5 million people were alive five years after diagnosis.

As conventional treatments may lead to fatigue, nausea, hair loss, and weakened immune function, cancer patients are looking for therapies that are less invasive, have fewer side effects, and support their overall health. This shift has sparked an increased interest in alternative treatments such as herbal remedies, immunotherapies, and biological treatments, which are believed to offer more targeted and holistic healing solutions. The failure of traditional therapies to cure certain cancer types or the recurrence of the disease after conventional treatment drives patients to explore alternative options that may offer more favorable outcomes.

The rising cancer incidence has also led to greater awareness and acceptance of alternative cancer treatments. Many patients, particularly in developed regions, are more open to exploring non-traditional therapies after experiencing the limitations and side effects of standard treatments. Alongside this, the growing body of research supporting the effectiveness of certain alternative cancer therapies, such as cannabis-based treatments, naturopathy, and immunotherapy, continues to bolster the credibility and demand for these options. As the global cancer epidemic worsens, the alternative cancer therapeutics market is expected to grow, driven by patient demand for more personalized and less toxic treatment regimens to combat cancer.

The growing prevalence of lifestyle disorders like diabetes and obesity, increasing healthcare spending, and the rapidly expanding diagnostic industry are fueling market growth. For example, the American Diabetes Association reports 1.2 million new diabetes diagnoses annually, with 11.6% of Americans affected in 2021. Additionally, the aging population, rising demand for laboratory automation, and greater awareness of preventive healthcare are contributing to market expansion.

Key Market Challenges

Lack of Standardized Regulations

The lack of standardized regulations in the global alternative cancer therapeutics market presents a significant challenge, hindering the widespread acceptance and integration of these treatments into mainstream oncology care. Unlike conventional cancer therapies, which are subject to rigorous regulatory frameworks such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), many alternative treatments-such as herbal remedies, supplements, and other non-traditional therapies-are not consistently regulated. This lack of standardization results in variations in product quality, safety, and efficacy, which can lead to confusion and mistrust among patients and healthcare providers.

Without a universal regulatory framework, the market is flooded with alternative treatments of varying potency, purity, and effectiveness. This inconsistency not only creates challenges for patients seeking reliable treatments but also for healthcare professionals who may find it difficult to recommend or integrate these therapies into their treatment plans. The absence of standardized manufacturing processes means that some alternative cancer treatments may contain harmful substances or contaminants, further raising concerns over patient safety.

The lack of regulation also impacts the clinical development of alternative cancer therapies. Without clear guidelines or standards, it becomes challenging for researchers and companies to conduct large-scale clinical trials to validate the effectiveness of these treatments. As a result, many alternative therapies lack the robust scientific evidence needed to prove their therapeutic value, leaving them on the fringes of cancer care. The patients may turn to unregulated alternative therapies when they seek relief from the side effects of conventional treatments. However, the risk of ineffective or potentially harmful treatments without regulatory oversight increases. A unified regulatory approach, focused on ensuring the safety, efficacy, and quality of alternative cancer therapies, would provide greater confidence to both patients and healthcare providers, promoting the responsible integration of these therapies into cancer treatment protocols.

Key Market Trends

Integration of Conventional and Alternative Therapies

The integration of conventional and alternative therapies is one of the most notable trends in the global alternative cancer therapeutics market, reflecting a shift towards more holistic, personalized, and patient-centered approaches to cancer care. Conventional cancer treatments such as chemotherapy, radiation, and surgery remain the primary modalities for cancer management. However, these treatments often come with significant side effects, such as fatigue, nausea, hair loss, and immune suppression, which can greatly affect a patient's quality of life. As a result, there has been growing interest in integrating alternative therapies, such as acupuncture, herbal remedies, and dietary supplements, into conventional treatment plans to mitigate these side effects and improve overall patient well-being.

Integrative oncology, which combines the best of both conventional and alternative therapies, is gaining acceptance among healthcare providers and patients alike. This approach not only focuses on targeting the cancer itself but also emphasizes addressing the physical, emotional, and psychological needs of cancer patients. By incorporating therapies like yoga, mindfulness meditation, and naturopathy, integrative oncology aims to improve the overall health of the patient and enhance the body's ability to cope with the side effects of aggressive cancer treatments.

Moreover, the growing body of research supporting the benefits of complementary therapies is further promoting this trend. Clinical studies have shown that treatments like acupuncture can reduce pain and nausea associated with chemotherapy, while certain herbal supplements may help enhance the effectiveness of conventional drugs. As a result, cancer care centers and hospitals are increasingly adopting integrative care models, and multidisciplinary teams are collaborating to provide comprehensive treatment plans that combine the latest advancements in both conventional and alternative medicine. This integration not only supports the growing demand for alternative cancer therapies but also opens new avenues for improving patient outcomes and quality of life.

Key Market Players

• Innovative Medicine, LLC
• Northwest Natural Health Clinic
• Immunotherapy Institute
• Georgia Cancer Specialists
• Holistic Bio Spa
• Johnson & Johnson
• Celgene Corporation
• Astellas Pharma, Inc.
• Novartis AG
• Merck KGaA

Report Scope:

In this report, the Global Alternative Cancer Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Alternative Cancer Therapeutics Market, By Therapy Type:

• Hormone Therapies
• Acupuncture and Dietary Supplements
• Others

Alternative Cancer Therapeutics Market, By Disease Type:

• Gastrointestinal
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Leukemia
• Lymphoma
• Melanoma
• Prostate Cancer
• Others

Alternative Cancer Therapeutics Market, By End Users:

• Hospitals and Clinics
• Cancer and Radiation Therapy Center
• Home Care
• Others

Alternative Cancer Therapeutics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Alternative Cancer Therapeutics Market.

Available Customizations:

Global Alternative Cancer Therapeutics Market report with the given market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Alternative Cancer Therapeutics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 5.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 5.2.3. By End Users (Hospitals and Clinics, Cancer and Radiation Therapy Center, Home Care, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Therapy Type
  • 5.3.2. By Disease Type
  • 5.3.3. By End Users
  • 5.3.4. By Region

6. North America Alternative Cancer Therapeutics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 6.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 6.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Alternative Cancer Therapeutics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Therapy Type
      • 6.3.1.2.2. By Disease Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Alternative Cancer Therapeutics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Therapy Type
      • 6.3.2.2.2. By Disease Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Alternative Cancer Therapeutics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Therapy Type
      • 6.3.3.2.2. By Disease Type
      • 6.3.3.2.3. By End User

7. Europe Alternative Cancer Therapeutics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 7.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 7.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Alternative Cancer Therapeutics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapy Type
      • 7.3.1.2.2. By Disease Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Alternative Cancer Therapeutics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapy Type
      • 7.3.2.2.2. By Disease Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Alternative Cancer Therapeutics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapy Type
      • 7.3.3.2.2. By Disease Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Alternative Cancer Therapeutics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Therapy Type
      • 7.3.4.2.2. By Disease Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Alternative Cancer Therapeutics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Therapy Type
      • 7.3.5.2.2. By Disease Type
      • 7.3.5.2.3. By End User

8. Asia-Pacific Alternative Cancer Therapeutics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 8.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 8.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Alternative Cancer Therapeutics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapy Type
      • 8.3.1.2.2. By Disease Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Alternative Cancer Therapeutics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapy Type
      • 8.3.2.2.2. By Disease Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Alternative Cancer Therapeutics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapy Type
      • 8.3.3.2.2. By Disease Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Alternative Cancer Therapeutics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapy Type
      • 8.3.4.2.2. By Disease Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Alternative Cancer Therapeutics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapy Type
      • 8.3.5.2.2. By Disease Type
      • 8.3.5.2.3. By End User

9. South America Alternative Cancer Therapeutics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 9.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 9.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Alternative Cancer Therapeutics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapy Type
      • 9.3.1.2.2. By Disease Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Alternative Cancer Therapeutics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapy Type
      • 9.3.2.2.2. By Disease Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Alternative Cancer Therapeutics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapy Type
      • 9.3.3.2.2. By Disease Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Alternative Cancer Therapeutics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 10.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 10.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Alternative Cancer Therapeutics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapy Type
      • 10.3.1.2.2. By Disease Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Alternative Cancer Therapeutics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapy Type
      • 10.3.2.2.2. By Disease Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Alternative Cancer Therapeutics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapy Type
      • 10.3.3.2.2. By Disease Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.1.1 Growing Prevalence of Cancer
• 11.1.2 Growing Healthcare Expenditure
• 11.2. Challenges
• 11.2.1 Lack of Awareness about New Therapies
• 11.2.2 High Cost of Treatment

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Alternative Cancer Therapeutics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Innovative Medicine, LLC
  • 15.1.1. Business Overview
  • 15.1.2. Product Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Northwest Natural Health Clinic
• 15.3. Immunotherapy Institute
• 15.4. Georgia Cancer Specialists
• 15.5. Holistic Bio Spa
• 15.6. Johnson & Johnson
• 15.7. Celgene Corporation
• 15.8. Astellas Pharma, Inc.
• 15.9. Novartis AG
• 15.10. Merck KGaA

16. Strategic Recommendations

17. About Us & Disclaimer